University Of Campinas, Brazil
Clinical trials sponsored by University Of Campinas, Brazil, explained in plain language.
-
Can a single dose of zoledronic acid safely treat bone loss in dialysis patients?
Disease control Not yet recruitingThis trial investigates how the drug zoledronic acid is processed in the body of people with chronic kidney disease who are on dialysis and also have osteoporosis. It aims to find the best dose—either 2.5 mg or 5 mg—given as a single intravenous injection during a dialysis sessio…
Phase: PHASE1 • Sponsor: University of Campinas, Brazil • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Brain surgery survivors: why do some lose memory years later?
Knowledge-focused Not yet recruitingThis study investigates why some people develop long-term thinking and memory problems after surgery to repair a ruptured brain aneurysm. Researchers will review past medical records and then bring in 150 adult survivors for brain scans and cognitive tests. The goal is to identif…
Sponsor: University of Campinas, Brazil • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC